The facility enables a wide range of research in the life sciences and environmental analysis, including:

* metabolomics and trace lipid analysis, the effects of chronic exposure to heavy metals;
* how residues of some veterinary drugs affect the food chain;
* analysis of toxins in food;
* identifying biomarkers for autism;
* factors affecting the immune system;
* researching inherited "knock-out diseases" like Fabry's disease; and
* an area of study called "environmental proteomics" (e.g. the protein profiles of organisms as they're exposed to different environmental compounds).

"Researchers at Duquesne University are doing fascinating work aimed at solving important problems, and we're very pleased to be part of the team," said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division.

The university received two National Science Foundation grants totaling nearly $1 million. The grants were used to acquire the following Agilent instrumentation and software:

* 1200 Series Rapid Resolution liquid chromatograph (LC);
* 1200 Series HPLC-Chip/MS systems;
* 6500 Series Accurate Mass Quadrupole Time of Flight LC/MS;
* 6400 Series triple quadrupole LC/MS; and
* 6200 Series Accurate Mass Time of Flight MS.

The Duquesne scientists also use Agilent Spectrum Mill for MassHunter Workstation software for rapid identification of large numbers of proteins and peptides.

"These powerful tools have become a mainstay for research and teaching in the school," said Dr. David W. Seybert, dean of the Bayer School of Natural and Environmental Sciences at Duquesne. "We are educating the next generation of scientists and it is imperative that their research training incorporates the most current generation of instrumentation available."

Under the leadership of Dr. Mitchell Johnson, associate professor, and Dr. H.M. "Skip" Kingston, professor in the Department of Chemistry and Biochemistry, the school has forged a partnership with Agilent, a leading supplier of mass spectrometers.

The center will serve as Agilent's regional showcase for the latest technologies in mass spectrometry, where researchers can see Agilent equipment in use investigating real problems. The center will provide a forum for the development of new applications and the testing of new ideas in search of important advances in life sciences, biomedicine, bioengineering, materials sciences, and other fields.

Next to instrument performance, flexibility is very important to the COE due to the wide variety of experiments it runs, Johnson said. "We also carefully evaluated service packages and what it costs to maintain the equipment. We were impressed with Agilent's approach."

Describing the impact of the new equipment, Johnson continued, "The difference between what we can do now and what we could do before is incredible. It's moved us into an entirely new echelon of research that is now possible at Duquesne."

In addition to its own research, the Duquesne COE also works closely with other community organizations. For example, the lab supports research investigations of a number of genetic-based disorders by the Allegheny General Hospital Allegheny Singer Research Institute and autism studies at the Children's Institute of Pittsburgh.

"As metrologists, we're working to solve important problems," said Kingston, a principal investigator. "We did a study of the epigenetics of immune system responses in autistic children screening 100 children for 70 toxins, and the TOF, Q-TOF and ICP-MS instruments were used for this. We're now researching toxins in food and their effects on children. For example, one form of selenium is healthful for humans, but there are 40 species of selenium and some of these are toxic."

"We evaluated all the major vendors and used similar samples to evaluate all the mass specs," said Dr. Partha Basu, associate professor, Department of Chemistry and Biochemistry, Duquesne University. "In addition to instrument performance, Agilent has been a very good fit in terms of support and collaboration. We have even co-authored posters and papers with their scientists."

Basu is investigating the protein profiles of organisms that metabolize nitrate in the hopes of developing bioremediation methods for removing metallic contamination from the environment. He's also studying the proteomic mechanisms of how Roxarsone, an anti-parasite drug administered to chickens, is converted to inorganic arsenic, which can then enter the food chain.

"We hope to develop organisms that can do many amazing things," said Basu.
About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 16,000 employees serve customers in more than 110 countries. Agilent had net revenues of $4.5 billion in fiscal 2009. Information about Agilent is available on the Web at www.agilent.com.

About Duquesne University

Duquesne is a private, coeducational university with more than 10,000 students. An extensive selection of undergraduate and graduate degree programs is offered across 10 schools of study. Duquesne is consistently ranked among the nation's top Catholic universities for its award-winning faculty and 132-year tradition of academic excellence. For more information, visit www.duq.edu.

— WebWireID113966 —

Aberrant DNA methylation is likely to be caused by a variety of environmental influences and is a molecular marker in multiple pathological processes such as cancer. Bisulfite modification of genomic DNA, followed by PCR amplification, cloning, and sequencing of individual PCR amplimers yields vital information on the methylation states of individual cytosines on individual DNA molecules.

With the BisulFlash(TM) technology, Epigentek makes a remarkable improvement over currently used DNA sodium bisulfite tools. Scientists at Epigentek have developed a proprietary means to effectively and simultaneously perform DNA denaturation and bisulfite conversion, contrary to traditional methods in which the two processes were performed separately. This breakthrough approach enables the DNA conversion process to not only be immensely faster but also achieve higher conversion efficiency and accuracy. Additionally, a unique protection reagent prevents over 90% of DNA loss, preserving important DNA recovery.

In just 30 minutes, converted DNA eluate can be obtained for use in MS-PCR, real time MS-PCR, methylation microarray, and especially next generation methylation sequencing and pyrosequencing. Other commercial kits on the market can take anywhere from 2 to 7 hours to complete a procedure with homebrew methods even taking up to 16 hours.

DNA methylation-related products are a large part of the world market of epigenetics which will reach $18.2bn by 2015 according to a 2010 report by Global Industry Analysts. By introducing the next generation BisulFlash(TM) method, Epigentek remains a key player in the research market. Back in 2007, Epigentek formed a strategic partnership with Sigma-Aldrich to provide its epigenetic technologies, including DNA methylation and ChIP, to the St. Louis company and to further the studies of epigenetics.

About Epigentek Group Inc.
Epigentek Group Inc. is a leading biotechnology company that focuses on developing and providing innovative technology and products as a complete and systematic solution for epigenetics-related research and drug discovery. Visit our website at www.epigentek.com

— WebWireID113802 —

'Exercises for Frozen Shoulder are basically small, simple movements that if done properly and consistently, contribute greatly to the healing of this painful, debilitating condition.' States Dr. Brogue

Medically referred to as adhesive capsulitis, the disease is caused by the inflammation of tissue around the shoulder joint. Additionally, abnormal bands of tissue called adhesions form in the area, and the effect is restricted motion and shoulder pain.

Dr. Brogue continues 'Arm dominance seems to have no bearing on the disease, as right shoulder pain happens more or less as often as right shoulder pain. It also afflicts men and women equally, mostly within the 40 to 60 age group.'

When asked about Yoga for frozen shoulder, Dr. Brogue has this to say: 'Although there are such things as yoga exercises for Frozen Shoulder and other more advanced therapies, simple stretches still work. The keys to any of these exercises is to adequately warm up the affected area first, and then apply the movements in a gentle, controlled way so as not overstress the tissues and make things worse instead of better.'

The recommended warm-up method according to Dr. Brogue 'Is to take a hot bath or shower for 10 to 15 minutes, focusing especially on the affected shoulder. Afterwards, while still warm, start performing the stretches. Start with small movements, moving the arm no more than a foot. If you feel increased pain, stop immediately as this could mean that you are overstressing tissues, or that your condition is not Frozen Shoulder at all but something with similar symptoms but which require a different kind of treatment or therapy.'

'Do your warm up, then immediately perform simple stretches and exercises for Frozen Shoulder to make the most of the treatment, and you should be back to normal before very long,' that is what the Good Doctor recommends.

For more Information About Frozen shoulder exercises visit http://frozenshouldercure.info

— WebWireID113264 —

The Brilliant III Ultra-Fast QPCR and QRT-PCR Master Mix reagents are designed to provide the fastest cycling times on any real-time PCR instrument. These reagents feature a newly engineered Taq, delivering a faster extension rate combined with a novel hot-start technology to minimize non-specific amplification. The ultra-fast reagents allow the completion of real-time experiments in less than 40 minutes, giving researchers quicker access to their data without compromising data reproducibility and quality.

"When compared to other fast QPCR reagents on the market, we observe minimal formation of non-specific and secondary products, providing improved sensitivity to deliver more accurate quantification," said Nick Price, Ph.D., product manager at Agilent Technologies. "We see time-to-results becoming increasingly important to researchers and are very pleased to offer the rapid-cycling benefits of the Brilliant III Ultra-Fast reagents."

The kits provide researchers with the flexibility to perform a variety of applications, including gene expression analysis, pathogen detection and SNP genotyping. The reagents are validated across a range of fast, real-time PCR systems and across a range of templates and targets. Earlier threshold cycle detection gives more reliable quantification across the entire range of template concentrations, including high and low concentrations.

The Brilliant III Ultra-FAST QPCR and QRT-PCR Master Mixes represent Agilent's third generation of real-time PCR reagents to be commercialized.
About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 16,000 employees serve customers in more than 110 countries. Agilent had net revenues of $4.5 billion in fiscal 2009. Information about Agilent is available on the Web at www.agilent.com.

— WebWireID113227 —

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that its research and diagnostic antibody unit AbD Serotec has demonstrated significant progress using the HuCAL-based technology platform to generate custom-made monoclonal antibodies for research and diagnostic use. Over the course of the last four years, AbD Serotec gradually improved success rates year-on-year starting at 80% in 2006 to reach 98% in 2009. This was mainly achieved through a high degree of automation in many aspects of the antibody generation process, by optimizing protocols and finally by the implementation of HuCAL PLATINUM, the latest and most powerful version of MorphoSys's antibody libraries.

"Thanks to the very effective technology and process development efforts at AbD Serotec, we have managed to deliver antibodies in almost every customer project we initiated in 2009. The success rates achieved by AbD Serotec in 2009 are significantly higher than the average success rate usually seen in the industry with animal-based methods, of around 75%,'' commented Dieter Feger, Head of AbD Serotec. "The HuCAL technology is making ever-increasing inroads into the diagnostics market as its intrinsic advantages are recognized."

About MorphoSys:

MorphoSys is an independent biotechnology company that develops novel antibodies for therapeutic, diagnostic and research applications. The Company's HuCAL technology is one of the most powerful methods available for generating fully human antibodies. By successfully applying this and other proprietary technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human health-care. Through its alliances with some of the world's leading pharmaceutical companies, MorphoSys has created a pipeline of more than 60 drug candidates. The Company is expanding its drug pipeline by adding new partnered programs, and by building a portfolio of fully-owned therapeutic antibodies. For its proprietary portfolio, the Company is focused on the areas of oncology and inflammation. Its most advanced program MOR103, a first-in-class, fully human antibody against GM-CSF, is currently tested in a Phase Ib/IIa trial in rheumatoid arthritis patients. Via its business unit AbD Serotec, MorphoSys is expanding the reach of its technologies in the diagnostics and research markets. MorphoSys is headquartered in Munich, Germany and listed on the Frankfurt Stock Exchange under the symbol "MOR". For further information, visit http://www.morphosys.com/

HuCAL®, HuCAL GOLD®, HuCAL PLATINUM® and RapMAT® are registered trademarks of MorphoSys AG

This communication contains certain forward-looking statements concerning the MorphoSys group of companies. The forward-looking statements contained herein represent the judgment of MorphoSys as of the date of this release and involve risks and uncertainties. Should actual conditions differ from the Company's assumptions, actual results and actions may differ from those anticipated. MorphoSys does not intend to update any of these forward-looking statements as far as the wording of the relevant press release is concerned.

— WebWireID113134 —

To address the needs of people interested in losing weight and getting in better shape, the website NewDietFitness.com has been launched this week. The site is intended to serve as a one-stop source of reviews of diet plans and a resource for fitness-minded people who want to learn more about diets, exercise and other fitness-related topics.

The website has already published reviews of some popular diet plans like Fat Burning Furnace, Fat Loss 4 Idiots, Strip That Fat, Cheat Yourself Thin and the Turbulence Training fitness program and plans to add new reviews and articles on diet and exercise as frequently as possible. While the site has only been live as of this week, their rapidly growing number of reviews and articles are certain to attract dieters in search of unbiased fitness and diet plan reviews as well as tips on weight loss and getting fit.

"There is a lot of information out there about diets and fitness plans already, to be sure - but the vast majority of this information comes directly from the makers of these programs; which doesn't bode well for anyone trying to find objective reviews. I started NewDietFitness.com to give people a place where they can go for honest reviews of exercise programs and diet plans - it's something that people have long wished existed, so I decided to take it upon myself to provide this resource to everyone trying to find the right way to lose weight and get in shape," says Ricardo D'Argence, the creator of NewDietFitness.com

You know what they say about giving the people what they want - and with this new diet and fitness resource, D'Argence seems to be doing exactly that. Response to the site has already been surprisingly strong and as the number of reviews and articles expands, D'Argence expects the site's audience to in his words, expand as quickly as his readers' waistlines shrink.

For more information, please visit: http://www.newdietfitness.com

— WebWireID112797 —

Amsterdam, The Netherlands - Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, today announced that Bulgaria has started deploying its smart cards to secure access to personal health records for the country's military personnel and their family.

Gemalto has vast experience in providing solutions for eHealth, and has proved itself as a strong and reliable partner in Slovenia, Germany, France, Finland, the UK, Gabon, Algeria, Mexico, etc.

In Bulgaria, Gemalto delivered double-slot readers and smart cards with the associated middleware to KIM-2000, a local company specialized in eHealth projects. KIM-2000 acts as prime contractor for the electronic health record system commissioned by the Military Medical Academy*. This innovative system optimizes medical treatments, simplifies and modernizes procedures and increases security for accessing health information.

The Gemalto card is compliant with the Identification Authentication Signature (IAS) European standard to ensure the highest level of security for accessing personal electronic health records. The patient and the healthcare professional simultaneously insert their own card into the double-entry Gemalto reader and type in their PIN code to enable viewing or modifying of the medical file, which is stored on a highly secure IT infrastructure. The patient can also view their personal data online, using the Gemalto reader and card to authenticate themselves.

The personal electronic health record is a complete electronic archive of the patient's medical history. It stores all existing medical documentation, including laboratory tests and results, X-ray pictures, all visual tests, electronic prescriptions, etc. It also contains the patient's blood group, allergies and genetic predisposition to diseases, health check ups, surgical interventions and all useful medical information.
The personal electronic health record enables healthcare professionals to immediately access a patient's medical data and therefore, make more accurate decisions, especially in emergency situations, for which there is a special section in the electronic health record, containing the most important relevant information.

'For securing our system, we needed a smart card that meets the stringent requirements of international and European standards,' commented Kalcho Hinov, Chairman of the Board, KIM-2000. 'Gemalto's European Standard-compliant IAS solution ensures trust and confidence and enables smoother, more efficient interaction between patients and healthcare professionals.'

'The implementation of an electronic health record system is a highly innovative project and Gemalto is proud to contribute to this venture alongside KIM-2000,' added Ari Bouzbib, Senior Vice President Identity and Government Programs at Gemalto. 'Through this initiative, Gemalto's digital security technology proves to be a key enabler to next-generation eHealth programs. These are intended to deliver optimized treatment for each patient with utmost security, while protecting the privacy of personal data.'

* The Military Medical Academy is under the authority of the Ministry of Defence and is the organization in charge of medical care for the Bulgarian Armed Forces.

About Gemalto

Gemalto (Euronext NL 0000400653 GTO) is the world leader in digital security with 2008 annual revenues of €1.68 billion, and 10,000 employees operating out of 75 offices, research and service centers in 40 countries.

Gemalto is at the heart of our evolving digital society. The freedom to communicate, travel, shop, bank, entertain, and work—anytime, anywhere—has become an integral part of what people want and expect, in ways that are convenient, enjoyable and secure.

Gemalto delivers on the growing demands of billions of people worldwide for mobile connectivity, identity and data protection, credit card safety, health and transportation services, e-government and national security. We do this by supplying to governments, wireless operators, banks and enterprises a wide range of secure personal devices, such as subscriber identification modules (SIM), Universal Integrated Circuit Card (UICC) in mobile phones, smart banking cards, smart card access badges, electronic passports, and USB tokens for online identity protection. To complete the solution we also provide software, systems and services to help our customers achieve their goals.

As the use of Gemalto's software and secure devices increases with the number of people interacting in the digital and wireless world, the company is poised to thrive over the coming years.

For more information please visit www.gemalto.com.

— WebWireID112454 —

The Endo-PAT2000 from Itamar Medical adds an important dimension to cardiovascular medicine by enabling physicians to reliably, easily and non-invasively measure endothelial function.

The Endo-PAT2000 has been extensively tested in major universities including the Mayo Clinic. It is able to predict the earliest clinically detectable stage of cardiovascular disease.

"What's more, treatment of endothelial dysfunction modifies cardiovascular outcomes." said Dr. Zarcone in a telephone interview.

"Simple modifications like diet, exercise, and the addition of an over-the-counter medication or a prescription agent can dramatically improve endothelial function" she added.

She further stated that "treatment options are considered in concert with the patient's primary physician and cardiologist if he or she has one, prior to determining a plan of action."

For more information please contact Elaine at 845-528-1898.

— WebWireID112357 —